Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

NMDA antagonists reported by Zeneca

July 5, 1996

Novo Nordisk claims mGluR antagonists for CNS disorders

July 5, 1996

Toyama discloses NGF-promoting agents

July 5, 1996

Sumitomo claims psychotropic lactam derivatives

July 5, 1996

5-HT2 ligands claimed by Janssen

July 5, 1996

Anxiolytic/antidepressant 5-HT1A receptor ligands from AHP

July 5, 1996

Lilly discloses antiobesity proteins

July 5, 1996

NPY1 ligands claimed by Pfizer

July 5, 1996

HHS scientist discovers cartilage formation stimulant

July 5, 1996

Kyowa Hakko isolates antitumor/antibacterial compound from Streptomyces

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...